MMP-9 can break down ECM, releasing a variety of angiogenic factors, including VEGF and fibroblast growth factor 2 (FGF2), that act upon nearby endothelial cells to promote tumor angiogenesis [57]. Here, MMP9 is linked to neoplasm.